1-4 of 4
Aloysius Ho, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early and Sustained Response to Azacytidine in High-Risk MDS Patients with Monosomy 7 Correlates with Increased Apoptosis and Not CDKN2B Demethylation.

Kavita K. Raj, MD, Alison M. John, PhD, Aloysius Ho, MD, Nicholas Shaun B. Thomas, PhD, Ghulam J. Mufti, MD
Journal: Blood
Blood (2005) 106 (11): 2530.
https://doi.org/10.1182/blood.V106.11.2530.2530
Published: 2005
Journal Articles

Second Reduced Intensity Transplants Are Effective and Well Tolerated in Older Patients with Relapsed Myeloid Malignancies. A Single Centre Report.

Frederick E. Chen, MD, Humayun N. Ahmad, MD, Pritesh Junagade, MD, Zi Lim, Stephen Devereux, MD, Antonio Pagliuca, MD, Aloysius Ho, MD, Ghulam J. Mufti, MD
Journal: Blood
Blood (2005) 106 (11): 5406.
https://doi.org/10.1182/blood.V106.11.5406.5406
Published: 2005
Journal Articles

5-Azacytidine in the Treatment of High Risk Myelodysplastic Syndromes: Clinical Response Can Occur without Demethylation of the CDKN2B , CDKN1A or TP73 Gene Promoters.

Kavita Raj, MD, Alison John, PhD, Aloysius Ho, MD, Nicholas Shaun B. Thomas, PhD, Ghulam J. Mufti, MD
Journal: Blood
Blood (2004) 104 (11): 2369.
https://doi.org/10.1182/blood.V104.11.2369.2369
Published: 2004
Journal Articles

Gemtuzumab Ozogamicin with Donor Leucocyte Infusions Is Safe and Effective Therapy for a Subgroup of Relapsed Acute Myeloid Leukaemia and Myelodysplastic Syndrome Following Allogeneic Haemopoietic Stem Cell Transplantation (HSCT).

Kavita Raj, MD, Maadh Aldouri, MD, Aloysius Ho, MD, Antonio Pagliuca, MD, Stephen Devereux, MD, Ghulam Mufti, MD
Journal: Blood
Blood (2004) 104 (11): 1806.
https://doi.org/10.1182/blood.V104.11.1806.1806
Published: 2004